Venous Thromboembolism

The 4% venous thromboembolism or VTE rate researchers found for 571 patients with tibial plateau fractures supports their theory that the non-weight-bearing sometimes needed after fracture treatment may predispose patients to develop a VTE.

Referring only patients with a positive D-dimer test to undergo compression ultrasonography, regardless of pretest probability, safely simplified the workup of deep vein thrombosis, according to study results published in Blood Advances.

World Thrombosis Day is observed Oct. 13.

A trial of ponatinib for certain patients with chronic myeloid leukemia demonstrated a trend toward dose-dependent efficacy and safety, according to study results presented at Society of Hematologic Oncology Annual Meeting.

Rivaroxaban reduced risk for recurrent venous thromboembolism compared with warfarin among patients with VTE and obesity, according to study results presented during International Society on Thrombosis and Haemostasis 2020 Virtual Congress.

Understanding the breadth of pulmonary complications among patients with rheumatic disease is critical to total patient care, according to a presenter at the 2020 Interdisciplinary Autoimmune Summit.

Patients with acute pulmonary embolism and metabolic syndrome had higher rates of recurrent venous thromboembolism, according to a new study published in Annals of the American Thoracic Society.

Trauma patients who underwent emergency general surgery appeared to have a twofold higher risk for venous thromboembolism than patients who underwent elective surgery, according to study results published in JAMA Surgery.

Abnormalities in blood clotting have been linked to increased mortality risk among patients with COVID-19.

Rivaroxaban (Xarelto, Janssen/Bayer) vs. enoxaparin for prevention of venous thromboembolism during immobilization after lower-limb nonmajor orthopedic surgery.